1Hayashi N, Ito I, Yanagisawa A,et al.Genetic diagnosis of lymph-node metastases in colorectal cancer. Lancet, 1995,345:1257-1259.
2Toshiki K, Yoshihiro F, Takehiro S, et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer,1995, 75:2214-2219.
3Peter K, Alfred Z, Ralf L, et al. Heterogenous expression of MEGA-A Genes in occult disseminated tumor cells: diagnosis of micrometastatic disease. Cancer Res, 2002,62:251-261.
5Kaplan JC,Kahn A,Chelly J.Illegitimate transcription: Its use in the study of inherited disease. Hum Mutat, 1992, 1:257.
6Wong IH, Lau WY, Leung T, et al. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res, 1999, 5:4021-4027.
7Miyamoto A, Nagano H, Sakon M, et al. Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR. Int J Oncol, 2001,18:527-532.
8O′Sullivan GC,Collins JK, O′Brien F, et al. Micrometastases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer. Gastroenterology, 1995,109: 1535-1540.
9Osborne M,Wong GY,Asina S,et al.Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow.Cancer Res,1991,51:2706-2709.
10Martin VM, Siewert C, Scharl A,et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp. Hematol, 1998,26: 252ˉ264.
二级参考文献3
1Chomczynski P,Sacchi N.Single-step method of RNA isolation by acid guanidinium thiocyanate - phenol-chloroformextraction[].Analytical Biochemistry.1987
4Nakatsura T, Yoshitake Y, Senju S, et al. Glypican-3, overexpressed specifically in human hepatocellular careinoma, is a novel tumor marker[J]. Biochem Biophys Res Commun, 2003,306(11) : 16-25.
5Fehr JE, Trotter GW, Oxford JT, et al. Comparison of Northern blot hybridization and a reverse transcriptase-ploymerase chain reac- tion technique for measurement of Mrna expression of metallopro- teinases and matrix components in a articular cartilage and synovial membrane from horses with osteoarthritis[J]. Am J Vet Res,2000, 62(7) :900-905.
6Hippo Y, Watanabe K, Watanabe A, et al. Identification of solulc NH2-teminal fragment of glypican-3 as a serological marker t earlystage hepatocellular carcinoma[J]. Cancer Res, 2004,64(2 2418-2423.
7Zhu ZW, Friess H, Wang L, et al. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinoma as from be- nign hepatic disorders[J].Gut, 2001,48(1) :558-564.
8Hippo Y,Watanabe K,Watanabe A,et al.Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.Cancer Res,2004,64:2418-2423.
9Mast AE,Higuchi DA,Huang ZF,et al.Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.Biochem J,1997,327:577-583.
10Sung YK,Hwang SY,Farooq M,et al.Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling.Exp Mol Med,2003,35:257-262.
